You got your shots, but you still worry: can you catch COVID-19? In the first four months of 2021, health officials were watching closely. They found that nearly 10,300 so-called 'breakthrough' infections were reported to the CDC. These cases happened in people across 46 states and territories who were considered fully vaccinated against the virus. At the time, about 101 million people in the U.S. had completed their vaccination series. It's important to understand what this number means. This was simply a count of cases that were reported to a national system. It doesn't tell us how sick people got, or how the vaccines performed at preventing severe illness or death. The report is a limited snapshot from a specific time, and many mild cases likely went unreported. It shows that while vaccination is powerful protection, it is not an impenetrable shield for every single person.
CDC reports nearly 10,300 breakthrough COVID-19 infections among 101 million fully vaccinated AmericansHow many vaccinated people got COVID? The CDC counted nearly 10,300 cases
AI-generated summary of the cited source, checked by automated accuracy review. How we work
The U.S. Centers for Disease Control and Prevention (CDC) published an observational surveillance report covering COVID-19 vaccine breakthrough infections from January 1 to April 30, 2021. The population included people in the United States who were fully vaccinated against COVID-19. The report documented breakthrough infections reported to the CDC from 46 states and territories.
The main results showed that almost 10,300 breakthrough infections were reported during this period. This occurred among an estimated population of approximately 101 million people who were fully vaccinated. The report did not provide effect sizes, a comparator group, p-values, confidence intervals, or the direction of any association.
Safety and tolerability data for the vaccines or the breakthrough infections were not reported in this summary. Key limitations include the observational and passive surveillance nature of the data, which relies on voluntary reporting and is subject to under-ascertainment. The absence of a comparator group prevents any calculation of vaccine effectiveness or relative risk. The timeframe represents an early period of mass vaccination, and patterns may have evolved. The report's practice relevance is limited to confirming that breakthrough infections were detected and reported through public health systems, which is expected with any vaccine. It does not provide evidence on the clinical severity of these infections or their comparative frequency.
More on SARS-CoV-2 infection
View Original Abstract ↓
Intrawound tobramycin plus vancomycin did not reduce deep infection risk compared with vancomycin alone in high-risk tibial fractures
Adding Antibiotics to Bone Surgery Didn't Lower Infection Risk
Related in Infectious Disease
From Other Specialties
